Table_3_The Temporal Expression of Global Regulator Protein CsrA Is Dually Regulated by ClpP During the Biphasic Life Cycle of Legionella pneumophila.xlsx by Zhen-huang Ge (7829171)

“…This cycle consists of a non-virulent replicative phase (RP) and a virulent transmissive phase (TP). …”

Data_Sheet_6_The Temporal Expression of Global Regulator Protein CsrA Is Dually Regulated by ClpP During the Biphasic Life Cycle of Legionella pneumophila.PDF by Zhen-huang Ge (7829171)

“…This cycle consists of a non-virulent replicative phase (RP) and a virulent transmissive phase (TP). …”

Data_Sheet_1_The Temporal Expression of Global Regulator Protein CsrA Is Dually Regulated by ClpP During the Biphasic Life Cycle of Legionella pneumophila.PDF by Zhen-huang Ge (7829171)

“…This cycle consists of a non-virulent replicative phase (RP) and a virulent transmissive phase (TP). …”

Data_Sheet_7_The Temporal Expression of Global Regulator Protein CsrA Is Dually Regulated by ClpP During the Biphasic Life Cycle of Legionella pneumophila.PDF by Zhen-huang Ge (7829171)

“…This cycle consists of a non-virulent replicative phase (RP) and a virulent transmissive phase (TP). …”

Data_Sheet_5_The Temporal Expression of Global Regulator Protein CsrA Is Dually Regulated by ClpP During the Biphasic Life Cycle of Legionella pneumophila.PDF by Zhen-huang Ge (7829171)

“…This cycle consists of a non-virulent replicative phase (RP) and a virulent transmissive phase (TP). …”

Data_Sheet_10_The Temporal Expression of Global Regulator Protein CsrA Is Dually Regulated by ClpP During the Biphasic Life Cycle of Legionella pneumophila.PDF by Zhen-huang Ge (7829171)

“…This cycle consists of a non-virulent replicative phase (RP) and a virulent transmissive phase (TP). …”

Data_Sheet_2_The Temporal Expression of Global Regulator Protein CsrA Is Dually Regulated by ClpP During the Biphasic Life Cycle of Legionella pneumophila.PDF by Zhen-huang Ge (7829171)

“…This cycle consists of a non-virulent replicative phase (RP) and a virulent transmissive phase (TP). …”

Data_Sheet_13_The Temporal Expression of Global Regulator Protein CsrA Is Dually Regulated by ClpP During the Biphasic Life Cycle of Legionella pneumophila.PDF by Zhen-huang Ge (7829171)

“…This cycle consists of a non-virulent replicative phase (RP) and a virulent transmissive phase (TP). …”

Data_Sheet_12_The Temporal Expression of Global Regulator Protein CsrA Is Dually Regulated by ClpP During the Biphasic Life Cycle of Legionella pneumophila.PDF by Zhen-huang Ge (7829171)

“…This cycle consists of a non-virulent replicative phase (RP) and a virulent transmissive phase (TP). …”

Table_1_The Temporal Expression of Global Regulator Protein CsrA Is Dually Regulated by ClpP During the Biphasic Life Cycle of Legionella pneumophila.DOCX by Zhen-huang Ge (7829171)

“…This cycle consists of a non-virulent replicative phase (RP) and a virulent transmissive phase (TP). …”

<i>as-</i>APF increases p53 expression by modulating USP2a and MDM2 in TRT-HU1, immortalized human normal bladder epithelial cells. by Jayoung Kim (153487)

“…(<b>B</b>) Endogenous USP2a level is rapidly decreased in response to <i>as</i>-APF treatment in TRT-HU1 cells. …”

This is the raw data used for this study. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Pre-operative versus post-operative symptoms. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Patient Demographics. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

“…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …”

Primary Microcephaly Gene <em>MCPH1</em> Shows Signatures of Tumor Suppressors and Is Regulated by miR-27a in Oral Squamous Cell Carcinoma by Thejaswini Venkatesh (385655)

“…Using bioinformatic approaches and luciferase assay, we showed that the 3′-UTR of <i>MCPH1</i> harbors two non-overlapping functional seed regions for miR-27a which negatively regulated its level. …”

Table 1_Targeting nail psoriasis: IL-17A inhibitors demonstrate site-specific superiority over IL-23 inhibitor in a 24-week dermoscopy-guided real-world cohort.docx by Xiamei Yan (21014921)

“…Objective<p>To compare the real-world clinical efficacy and safety of interleukin (IL)-17A inhibitors (secukinumab [SEC] and ixekizumab [IXE]) versus the IL-23 inhibitor guselkumab (GUS) in patients with nail psoriasis, with a focus on site-specific biologic therapeutic responses (nail matrix vs. nail bed) in a 24-week prospective observational cohort.…”

Deletion of <i>bipA</i> in pathogenic <i>S</i>. Typhimurium strains resulted in reduced invasion into HCT116 cells. by Eunsil Choi (8271039)

Membrane potential measurements when SLO3 channel antagonists are present in capacitated wild-type and SLO3 mutant sperm; no significant changes in ion permeabilities are seen comp... by Julio C. Chávez (399841)

“…<p>Curves shown are GHK fits to wild-type (A) and SLO3 mutant sperm (B). When SLO3 channels are blocked in wild-type sperm, with either Ba²⁺ (1 mM), or clofilium (50 µM), no hyperpolarization is noted during capacitation and membrane permeability values are similar to those of non-capacitated wild-type sperm. …”

Tunel detection of myocardial apoptosis. by Qingqing Hao (5464070)

“…<div><p>Background</p><p>Cardiac contractility modulation (CCM) is non-excitatory electrical stimulation for improving cardiac function. …”